Skip to main content
Clinical Trials/NCT02966054
NCT02966054
Completed
Not Applicable

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial

University of California, San Francisco1 site in 1 country42 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colon Cancer
Sponsor
University of California, San Francisco
Enrollment
42
Locations
1
Primary Endpoint
Physical activity
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Epidemiologic data consistently indicate that colorectal cancer survivors can improve their quality-of-life and prognosis by engaging in physical activity. This study aims to build on this epidemiologic work and translate the findings to inform and change patient behavior. The specific aims are to: (1) Develop a mobile technology physical activity intervention among colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized controlled trial utilizing mobile technology to increase physical activity among 40 men and women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and educational print materials; participants in the control arm will receive educational print materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up assessment.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
June 20, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erin Van Blarigan

Assistant Professor

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

  • stage I-III colon or rectal adenocarcinoma
  • completed standard cytotoxic chemotherapy if medically indicated
  • be considered disease-free at baseline
  • be able to speak and read English
  • have no contra-indication to moderate to vigorous aerobic exercise
  • be able to walk unassisted
  • be inactive at baseline (\<150 min/week of moderate physical activity)
  • have access to a mobile phone
  • be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Physical activity

Time Frame: 12-weeks

Change in total physical activity assessed via ActiGraph GT3X+ accelerometers

Secondary Outcomes

  • Quality-of-life (SF--36)(12-weeks)
  • Colorectal cancer-specific quality-of-life (FACT-C)(12-weeks)
  • Fitbit wear time (# days with data / # days of observation)(12-weeks)
  • Response to text messages (# of messages responded to / # of messages that asked for a response)(12-weeks)

Study Sites (1)

Loading locations...

Similar Trials